136 related articles for article (PubMed ID: 38353491)
21. Fusion of the TBL1XR1 and HMGA1 genes in splenic hemangioma with t(3;6)(q26;p21).
Panagopoulos I; Gorunova L; Bjerkehagen B; Lobmaier I; Heim S
Int J Oncol; 2016 Mar; 48(3):1242-50. PubMed ID: 26708416
[TBL] [Abstract][Full Text] [Related]
22. Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signaling.
Lu J; Bang H; Kim SM; Cho SJ; Ashktorab H; Smoot DT; Zheng CH; Ryeom SW; Yoon SS; Yoon C; Lee JH
Oncogene; 2021 Feb; 40(5):922-936. PubMed ID: 33288885
[TBL] [Abstract][Full Text] [Related]
23. De novo non-synonymous TBL1XR1 mutation alters Wnt signaling activity.
Nishi A; Numata S; Tajima A; Zhu X; Ito K; Saito A; Kato Y; Kinoshita M; Shimodera S; Ono S; Ochi S; Imamura A; Kurotaki N; Ueno SI; Iwata N; Fukui K; Imoto I; Kamiya A; Ohmori T
Sci Rep; 2017 Jun; 7(1):2887. PubMed ID: 28588275
[TBL] [Abstract][Full Text] [Related]
24. TBL1XR1 associated intellectual disability, a new missense variant with dysmorphic features plus autism: Expanding the phenotypic spectrum.
Arroyo Carrera I; Fernández-Burriel M; Lapunzina P; Tenorio JA; García Navas VD; Márquez Isidro E
Clin Genet; 2021 Jun; 99(6):812-817. PubMed ID: 33527360
[TBL] [Abstract][Full Text] [Related]
25. TBL1XR1 is involved in c-Met-mediated tumorigenesis of human nonsmall cell lung cancer.
Zhang T; Liu C; Yu Y; Geng J; Meng Q; Xu S; Zhou F; Chen Y; Jin S; Shen J; Pan B; Meng F; Liu F
Cancer Gene Ther; 2020 Apr; 27(3-4):136-146. PubMed ID: 31243347
[TBL] [Abstract][Full Text] [Related]
26. Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature.
Magro CM; Yang A; Fraga G
Am J Dermatopathol; 2013 May; 35(3):319-26. PubMed ID: 23190506
[TBL] [Abstract][Full Text] [Related]
27. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer.
Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L
Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172
[No Abstract] [Full Text] [Related]
28. TBL1XR1 predicts isolated tumor cells and micrometastasis in patients with TNM stage I/II colorectal cancer.
Liu H; Liu Z; Li K; Li S; Song L; Gong Z; Shi W; Yang H; Xu Y; Ning S; Ismail S; Chen Y
J Gastroenterol Hepatol; 2017 Sep; 32(9):1570-1580. PubMed ID: 28127799
[TBL] [Abstract][Full Text] [Related]
29. Pierpont syndrome associated with the p.Tyr446Cys missense mutation in TBL1XR1.
Slavotinek A; Pua H; Hodoglugil U; Abadie J; Shieh J; Van Ziffle J; Kvale M; Lee H; Kwok PY; Risch N; Sabbadini M
Eur J Med Genet; 2017 Oct; 60(10):504-508. PubMed ID: 28687524
[TBL] [Abstract][Full Text] [Related]
30. Acute promyelocytic leukemia with a cryptic insertion of RARA into TBL1XR1.
Osumi T; Watanabe A; Okamura K; Nakabayashi K; Yoshida M; Tsujimoto SI; Uchiyama M; Takahashi H; Tomizawa D; Hata K; Kiyokawa N; Kato M
Genes Chromosomes Cancer; 2019 Nov; 58(11):820-823. PubMed ID: 31350930
[TBL] [Abstract][Full Text] [Related]
31. Pierpont syndrome due to mutation c.1337A>G in TBL1XR1 gene.
Tesarova M; Baxova A; Hansikova H; Lambert L; Vondrackova A; Leiska A; Zeman J
Clin Dysmorphol; 2022 Jul; 31(3):145-148. PubMed ID: 35165208
[No Abstract] [Full Text] [Related]
32. miR-199a/214 cluster enhances prostate cancer sensitiveness to nimotuzumab via targeting TBL1XR1.
Hu S; Zhou Q; Lu Q; Guo X; Wang Y; Duan YX
Kaohsiung J Med Sci; 2023 Dec; 39(12):1178-1189. PubMed ID: 37772770
[TBL] [Abstract][Full Text] [Related]
33. TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation.
Lemattre C; Thevenon J; Duffourd Y; Nambot S; Haquet E; Vuadelle B; Genevieve D; Sarda P; Bruel AL; Kuentz P; Wells CF; Faivre L; Willems M
Am J Med Genet A; 2018 Dec; 176(12):2813-2818. PubMed ID: 30365874
[TBL] [Abstract][Full Text] [Related]
34. TBL1XR1 induces cell proliferation and inhibit cell apoptosis by the PI3K/AKT pathway in pancreatic ductal adenocarcinoma.
Gu JF; Fu W; Qian HX; Gu WX; Zong Y; Chen Q; Lu L
World J Gastroenterol; 2020 Jul; 26(25):3586-3602. PubMed ID: 32742128
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-34c-5p Reduces Malignant Properties of Lung Cancer Cells through Regulation of TBL1XR1/Wnt/β-catenin Signaling.
Lai W; Yue Y; Zeng G
Curr Mol Med; 2024; 24(1):114-122. PubMed ID: 36999182
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of circ_0026579 ameliorates lipopolysaccharide (bacterial origin)-induced inflammatory injury in bronchial epithelium cells by targeting miR-338-3p/TBL1XR1 axis.
Cheng S; Chen C; Wang L
Transpl Immunol; 2022 Oct; 74():101635. PubMed ID: 35636669
[TBL] [Abstract][Full Text] [Related]
37. CD5-positive marginal zone lymphoma: Clinicopathological features and survival outcomes.
Xia Y; Ge J; Sun Z; Nan F; Wan W; Xu D; Zhang M; Fu X
Leuk Res; 2022 Jun; 117():106840. PubMed ID: 35468520
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-130a-3p suppresses cell migration and invasion by inhibition of TBL1XR1-mediated EMT in human gastric carcinoma.
Wang S; Han H; Hu Y; Yang W; Lv Y; Wang L; Zhang L; Ji J
Mol Carcinog; 2018 Mar; 57(3):383-392. PubMed ID: 29091326
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma.
Ikeda JI; Kohara M; Tsuruta Y; Nojima S; Tahara S; Ohshima K; Kurashige M; Wada N; Morii E
Hum Pathol; 2017 Jan; 59():70-79. PubMed ID: 27666766
[TBL] [Abstract][Full Text] [Related]
40. FOXP1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach.
Baró C; Espinet B; Salido M; Colomo L; Luño E; Florensa L; Ferrer A; Salar A; Campo E; Serrano S; Solé F
Histol Histopathol; 2009 Nov; 24(11):1399-404. PubMed ID: 19760589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
